GoodRx Partners with Viatris to Provide Up to 85% Savings on Brand Medications
GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications GoodRx the leading platform for prescription savings in the U.S., announced a new collaboration with Viatris,…
Planet DDS 2026 Dental Outlook Reports More New Patients and Fewer No-Shows Across the Industry
Planet DDS 2026 Dental Outlook Shows More New Patients, Fewer No-Shows Across the Industry Planet DDS, a leading provider of cloud-based, enterprise-grade dental software solutions, announced the release of its 2026…
Tempus AI Study Reveals Impact of Advanced Genomic Profiling in Detecting Actionable Findings
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings Tempus AI, Inc. a technology company leading the adoption of AI to advance precision…
Veristat Broadens Regulatory and Clinical Services for Chinese Companies Seeking EU Market Entry
Veristat Expands Regulatory and Clinical Services to Chinese Drug and Device Companies Seeking Efficient Way to Enter European Markets Veristat, a global clinical research organization (CRO) and consultancy specializing in…
Precision BioSciences Secures U.S. Patent Allowances for PBGENE-HBV Program
Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program Precision BioSciences, Inc. a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for…
Parabilis Medicines’ Zolucatetide Receives FDA Orphan Drug Designation for Desmoid Tumor Treatment
Parabilis Medicines’ Zolucatetide, the First and Only Direct Inhibitor of the Elusive β-catenin:TCF Interaction, Receives FDA Orphan Drug Designation for the Treatment of Desmoid Tumors Parabilis Medicines, a clinical-stage biopharmaceutical…
Curatis Grants Neupharma Exclusive Japan Rights for Corticorelin (C-PTBE-01)
Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan Curatis Holding AG and Neupharma Co., Ltd. a…
TIXiMED: Oral TIX100 Prevents Post-GLP-1 Weight Regain in Preclinical Study
TIXiMED Reports Promising Preclinical Results for Oral TIX100 in Preventing Weight Regain After GLP-1 Therapy TIXiMED a clinical-stage pharmaceutical company focused on developing innovative treatments for diabetes and metabolic diseases,…
Verasonics Updates Vantage NXT with New Ultrasound Features
Verasonics Announces Vantage® NXT Platform Update Featuring Encoder Integration, Focused Ultrasound 2D/3D Software, New 8 MHz Matrix Array Transducer Verasonics, Inc., the leader in research ultrasound, announced the release of a significant…
GeneDx Launches Genetic Testing Program with Zevra Therapeutics
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C GeneDx the leader in rare disease diagnosis and improving health through the…
QT Imaging Wins FDA Clearance for Enhanced Breast Acoustic CT Scanner
QT Imaging Receives FDA Clearance for Its Breast Acoustic CT Scanner Enhanced Configuration to Improve Posterior Breast Imaging Coverage QT Imaging Holdings, Inc. a medical device company dedicated to transforming…
Butterfly Network Names David Horsley SVP of Innovation
Butterfly Network Appoints David Horsley as Senior Vice President, Innovation – Butterfly Embedded™ Butterfly Network, Inc. a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced…